awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26747666-ACBF53C7-219D-49B6-804D-793E56A96ADE
Q26747666-ACBF53C7-219D-49B6-804D-793E56A96ADE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747666-ACBF53C7-219D-49B6-804D-793E56A96ADE
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
P2860
Q26747666-ACBF53C7-219D-49B6-804D-793E56A96ADE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747666-ACBF53C7-219D-49B6-804D-793E56A96ADE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b983e764be4731a6262f3cb5a50d934462c76516
P2860
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors.